Genetron Holdings Limited (GTH)
| Market Cap | 1.46B |
| Revenue (ttm) | 64.91M |
| Net Income (ttm) | -469.27M |
| Shares Out | 88.87M |
| EPS (ttm) | -0.55 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 175,940 |
| Open | 15.82 |
| Previous Close | 16.46 |
| Day's Range | 14.51 - 16.17 |
| 52-Week Range | 9.03 - 31.54 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 21.97 (+50.7%) |
| Est. Earnings Date | Nov 8, 2021 |
About GTH
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of hepatocellular carcinoma. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product based on semiconductor se...
Financial Performance
In 2020, GTH's revenue was 424.49 million, an increase of 31.25% compared to the previous year's 323.43 million. Losses were -3.07 billion, 354.0% more than in 2019.
Financial numbers in millions CNYFinancial StatementsAnalyst Forecast
According to 4 analysts, the average rating for GTH stock is "Strong Buy." The 12-month stock price forecast is 21.97, which is an increase of 50.69% from the latest price.
News
Genetron Health Unveils 13 Cancer Research findings at ESMO Congress 2021
BEIJING, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in molecu...
Genetron Added to FTSE Russell Global Equity Index Series
BEIJING, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that Genetron will be added to the below FTSE Global Equity Index...
Genetron Health's Co-Founder and Chief Scientific Officer Awarded International Prize for Translational Neuroscience ...
BEIJING, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecula...
Genetron Holdings: Q2 Earnings Insights
Shares of Genetron Holdings (NASDAQ:GTH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were up 31.58% year over year to ($0.13), which beat the estimate...
Genetron Health Reports Second Quarter 2021 Unaudited Financial Results
BEIJING, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering...
Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference
BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health Reaches Strategic Partnership with Yikon Genomics, Expanding S5 Platform's Reach to Reproductive Heal...
BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health to Announce Second Quarter 2021 Financial Results and Host Investor Call on August 24, 2021
BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health Tops NCCL's External Quality Assessment of NGS-based Comprehensive Genomic Profiling for Solid Tumors...
BEIJING, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health Partners with Guizhou Province's Dafang County to Lead Liver Cancer Early Screening Project
BEIJING, July 29, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in China
BEIJING, July 26, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx) kit, de...
Genetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA Reference Panel Comparative Data of it...
The CE Mark and comparative data highlight the Company's capability in providing high quality and consistent testing products The CE Mark and comparative data highlight the Company's capability in provi...
Genetron Health Enters into Platform Partnership with World Economic Forum
BEIJING, July 02, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health Releases 16 New Research Results at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
BEIJING, June 04, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offerin...
Genetron Health Reports First Quarter 2021 Unaudited Financial Results
BEIJING, May 24, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering ...
Genetron Health Announces Strategic Partnership with JD Health to Create Innovative Solutions for Full-cycle Cancer M...
BEIJING, May 20, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering...
3 Small Cap Stocks That Are Short Squeeze Candidates
Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.
Genetron Health Announces Strategic Partnership with Siemens Healthineers to Promote Precision Oncology for Lung Cancer
SHANGHAI--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profi...
Genetron Health to Announce First Quarter 2021 Financial Results and Host Investor Call on May 24, 2021
BEIJING, May 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering ...
Genetron Health to Present at Upcoming Investor Conferences
BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offeri...
Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests...
Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit
BEIJING, April 01, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offeri...
Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH) sponsored a Science/AAAS Webinar, “Early cancer screening today and tomorrow: Exploring liquid biops...
Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guid...
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profil...
Genetron Health Releases New Data Results of HCCscreen™ for Liver Cancer Early Screening in China
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests...